Childhood Bullous Pemphigoid


Last updated: March 2024

What is childhood bullous pemphigoid?

Childhood bullous pemphigoid is an extremely rare form of the bullous pemphigoid, which is an autoimmune blistering disease. Given its rarity, the exact incidence of the condition is unknown.

Who gets childhood bullous pemphigoid?

Childhood bullous pemphigoid occurs in children under 18 years of age.

What causes childhood bullous pemphigoid?

Like adult bullous pemphigoid, childhood bullous pemphigoid occurs when cells of the body’s immune system produce proteins (autoantibodies) which attack and damage specific proteins of the basement membrane zone (known as BP180 and BP230). These proteins are critical in attaching the top layer of skin cells (the epidermis) to the underlying layer (the dermis). If the basement membrane proteins are damaged the top and bottom layers of the skin break apart causing blister formation.

The cause of the immune attack on the child’s skin is unknown.

What does childhood bullous pemphigoid look like?

Similar to adult bullous pemphigoid, childhood bullous pemphigoid is characterised by tense fluid-filled blisters accompanied by redness and itching. There may also be patches of itchy redness without blisters before the onset of blisters.

The eruption may occur anywhere on the child’s body. Younger children (under one year of age) may have a more extensive rash and their extremities and facial areas are more likely to be affected. There have been some reports of mucous membrane involvement.

How is childhood bullous pemphigoid diagnosed?

Childhood bullous pemphigoid is diagnosed clinically.

Diagnosis may be delayed as it often takes some time for the blisters to emerge.

The following tests are usually required:

  • Skin biopsies – a biopsy of the edge of a blister for routine pathology; a second biopsy of skin close to a blister can be sent for direct immunofluorescence which looks for the presence of autoantibodies in the skin.
  • Blood tests – these test for autoantibodies in the blood.

How is childhood bullous pemphigoid treated?

Treatment options will vary depending on the individual and their needs.

There is currently no cure, but it is expected that symptoms will gradually improve over time. The aim of treatment is to reduce blister formation, relieve the pruritus (itchiness), promote wound healing, and minimise the side effects of treatment.

Individuals with mild disease

  • Potent topical corticosteroid

Individuals with more aggressive disease

Oral medications are often required. These can include:

  • First-line treatments, such as oral prednisolone
  • Second-line treatments, such as topical immunomodulators, dapsone, azathioprine, or mycophenolate
  • Omalizumab and dupilumab

What is the likely outcome of childhood bullous pemphigoid?

Childhood bullous pemphigoid seems to improve with time. In previously reported cases, almost all children reached complete remission within 1 to 2 years. 1 The relapse rate is generally low. However, it can be triggered by infections or if oral corticosteroid treatment is weaned too quickly.

The initial presentation of childhood bullous pemphigoid can be severe. However, unlike adult bullous pemphigoid, the condition usually improves over time.

  1. Mitra D, Bhatnagar A, Singh GK, Sandhu S. Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab. Indian Dermatol Online J. 2022 Mar 3;13(2):248-251. doi: 10.4103/idoj.idoj_223_21. PMID: 35287397; PMCID: PMC8917490.
Dr Cathy Zhao & Prof Dedee MurrellMarch 2024
Dr Cathy Zhao & Prof Dedee MurrellJuly 2015


2019 © Australasian College of Dermatologists.

You may use for personal use only. Please refer to our disclaimer.